Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Aclaris Therapeutics Inc
About ACRS
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing novel small and large molecule product candidates for immuno-inflammatory diseases. Its proprietary KINect drug discovery platform coupled with its integrated discovery approach to small and large molecules enables the Company to identify and advance product candidates. It provides contract research services to third parties enabled by its early-stage research and development expertise. The contract research segment is engaged in the provision of laboratory services. Its product candidate pipeline includes Bosakitug (ATI-045), ATI-2138 and ATI-052. The Bosakitug (ATI-045) is an investigational, novel, humanized anti-Thymic stromal lymphopoietin (TSLP) monoclonal antibody that specifically binds to human TSLP, blocking its interaction with the receptor complex and disrupting signal transduction. Its other investigational product candidate is Lepzacitinib (ATI-1777).
Find out what a historical investment in Aclaris Therapeutics Inc would be worth today using our ACRS stock calculator.
Market Capitalisation
$631.28M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
929.25K
High today
$4.82
Low today
$4.49
Open price
$4.70
52-week high
$5.15
52-week low
$1.16
Ready to start your investing journey with Stake?
Open an accountHow do I buy ACRS shares in Australia?
Buying ACRS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Aclaris Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ACRS
What is the ticker symbol of Aclaris Therapeutics Inc?
The ticker symbol for Aclaris Therapeutics Inc is ACRS.
How much is one share of ACRS?
One share of ACRS is valued at $4.50 as of 16 May 2026.
What is the market capitalisation of Aclaris Therapeutics Inc ACRS?
As of 16 May 2026 Aclaris Therapeutics Inc has a market cap of $631.28M.
What is the 52-week high for Aclaris Therapeutics Inc stock?
The Aclaris Therapeutics Inc 52-week high stock price is $5.15.
What is the 52-week low for Aclaris Therapeutics Inc stock?
The Aclaris Therapeutics Inc 52-week low stock price is $1.16.
Can I buy ACRS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ACRS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ACRS on Stake
- Buy ACRS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ACRS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ACRS related stocks